PharVision Advisers
TKC icon

PharVision Advisers’s Turkcell TKC Stock Holding History

PharVision Advisers’s Portfolio TKC Stock Details TKC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-12,671
Closed -$74.5K – 71
2026
Q2 		$74.5K Sell
12,671
-6,112
-33% -$37.5K 1.4% 37
2026
Q1 		$113K Buy
18,783
+299
+2% +$1.9K 1.15% 38
2025
Q4 		$101K Buy
+18,484
New +$108K 0.05% 654

Other funds holding TKC

Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Ethic Inc
Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return
Quadrant Capital Group
Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

PharVision Advisers's TKC Position: Q3 2026 in Review

PharVision Advisers sold out of Turkcell (TKC) in Q3 2026, closing a stake of 12,671 shares — an estimated $74.5K sold.

PharVision Advisers first reported a position in TKC in Q4 2025 and held it in 3 quarters. The position peaked at $113K in Q1 2026. 74 funds tracked by Wall St. Rank hold TKC as of Q3 2026.

  • PharVision Advisers reported no remaining Turkcell position as of Q3 2026 after selling out during the quarter.
  • PharVision Advisers sold 12,671 Turkcell shares in Q3 2026, an estimated $74.5K.
  • PharVision Advisers first reported a position in Turkcell in Q4 2025 and held it in 3 quarters.
  • PharVision Advisers's Turkcell position peaked at $113K in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Turkcell as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.